361 Capital’s Labcorp LH Stock Holding History

361 Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$212K	Buy	+1,484	New	+$205K	0.1%	293
2019 Q3	–	Sell	-8,090	Closed	-$1.2M	–	345
2019 Q2	$1.2M	Buy	+8,090	New	+$1.13M	0.21%	199
2018 Q2	–	Sell	-15,102	Closed	-$2.1M	–	358
2018 Q1	$2.1M	Buy	+15,102	New	+$2.22M	0.52%	37

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

361 Capital's LH Position: Q2 2020 in Review

361 Capital opened a new position in Labcorp (LH) in Q2 2020: 1,484 shares worth $212K. The stake represents 0.1% of the portfolio and ranks #293 among its holdings. This is a return to the name: 361 Capital previously reported a position in LH as recently as Q2 2019.

361 Capital first reported a position in LH in Q1 2018 and has held it in 3 quarters since. The position peaked at $2.1M in Q1 2018. 799 funds tracked by Wall St. Rank hold LH as of Q2 2020.

361 Capital held 1,484 shares of Labcorp worth $212K as of Q2 2020.
Labcorp was a new 361 Capital position in Q2 2020.
Labcorp made up 0.1% of 361 Capital's portfolio in Q2 2020, its #293 holding.
361 Capital first reported a position in Labcorp in Q1 2018 and has held it in 3 quarters since.
361 Capital's Labcorp position peaked at $2.1M in Q1 2018.
799 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.